A watch list is not a buy list. The difference matters, and most year-end previews elide it. What follows is seven names we think earn a position into 2027, each with a thesis short enough to fit on an index card and an invalidator specific enough that you would actually act on it. If we are wrong, we would like to know quickly. Convex outcomes require disciplined exits.
One blue-chip rerate candidate. Two mid-career women painters. One African diaspora name. One sculpture and installation artist. One figuration specialist. One process-based painter. The cohort is deliberately mixed because the market is not a single argument, and a portfolio that pretends otherwise is a portfolio asking to be stopped out.
1. Marlene Dumas — the blue-chip rerate
Thesis: Dumas is the rare living blue-chip whose auction record has lagged her institutional weight by a full tier. The 2022 Palazzo Grassi retrospective ratified a lineage, post-war European figuration, that her market had not fully priced. With a narrow supply pipeline and long-held private hands finally turning, there is room for a two-turn move on the best canvases before the name is fully repriced.
Invalidator: Two consecutive evening sale buy-ins on major Dumas lots with fresh-to-market provenance. If the trade cannot clear a clean consignment at a serious estimate, the rerate is stalled, and holders will begin to discount the rest of the inventory. That is the signal. It has not come. If it comes in two sales running, walk.
2. Jadé Fadojutimi — the speed problem
Thesis: Fadojutimi is the most interesting young abstractionist working at scale, and the institutional stack is real. Tate acquisition. A Hepworth Wakefield show. Gagosian representation, which, whatever you think of it, closes the distribution question. The thesis is not that she keeps going vertical. It is that she survives the cooldown without losing her institutional momentum, and compounds from a base.
Invalidator: A single evening sale buy-in paired with a day sale print below the low estimate in the same season. Fadojutimi’s tape has moved too fast for her own good. A real correction is healthy. A correction combined with visible dealer frustration, which you can read in consignment quality, is a different animal. Easton Cain has been quietly warning about this cohort for two years, and the warning deserves weight.
3. Lucy Bull — the process thesis
Thesis: Bull is the process painter of her generation, which matters because process-based work tends to hold better than gestural figuration once a market cools. Her surfaces are genuinely difficult to produce and genuinely difficult to fake, which is an underrated moat. David Kordansky carries her well. The secondary has been disciplined, largely because the primary has been disciplined.
Invalidator: If Bull leaves Kordansky, the thesis resets. The relationship is the infrastructure, and the consignment pipeline has been managed in a way that requires an aligned dealer. A move to a larger shop without a clear reason, or worse, a multi-gallery split that fragments the primary market, would invalidate the hold.
4. Jennifer Packer — the narrow pipeline
Thesis: Packer produces slowly and carefully. The scarcity is real, not manufactured, and the institutional line, the Whitney, the Serpentine, the Carnegie, has been built on substance. The market has not yet forced her into the kind of auction volume that punishes most of her peers. If that holds, the price discovery through 2027 will be on her terms, not the trade’s.
Invalidator: A noticeable acceleration in auction volume, say, four or more major Packer lots across the London and New York November sales combined, would mean holders are beginning to turn. That would compress the scarcity premium, which is the entire argument. The current pace is three or fewer per season. Watch the count.
5. Simone Leigh — sculpture, finally
Thesis: Leigh is the first African diaspora sculptor of her generation to build a market that is priced to her institutional position rather than lagging it by a decade. The 2022 Venice Biennale did the work retrospectives usually do, and the Hauser and Wirth machine has handled the secondary with discipline. Sculpture is harder to flip, which has kept the holder base serious.
The cohort of collectors buying Leigh today is measurably different from the cohort that bought ultra-contemporary painting in 2021. That is the argument.
Invalidator: A large-scale bronze surfacing at auction with a sub-three-year hold period. Leigh’s market has, to date, been protected by long-term holders. A fast flip from a serious collector would signal either liquidity pressure in the base or a thesis break at the top. Either way, the position tightens.
6. Salman Toor — the figuration hold
Thesis: Toor has done the hard thing in figurative painting, which is to make work that reads as both personal and historical, and the museum pipeline reflects it. The Whitney show. The Baltimore Museum acquisition. His auction record has moved in a controlled way, which suggests a primary market that has been actively managing secondary supply. Lucian Poe has flagged his consignment control as a structural positive in private notes for two years running.
Invalidator: If Toor’s auction record prints north of a threshold that his primary market has not endorsed, say, a number materially above his current gallery pricing on comparable works, the control has broken. That would pull forward supply and compress the compounding case. A disciplined market can be read on the tape. Watch the print.
7. Tschabalala Self — mid-career discipline
Thesis: Self has compounded institutional weight at a pace that the market has partially, but not fully, priced. The stitched and collaged figures are distinctive enough that the fakes problem, a real drag on peer names, has not surfaced. Her secondary volume is modest, which is healthy. The case is not a breakout. The case is a steady rerate over 24 months on clean inventory.
Invalidator: A rapid expansion in day sale volume without a corresponding institutional catalyst. Self’s market is working precisely because supply has been rationed. If that rationing breaks, either because the primary shifts or holders start turning, the compounding thesis weakens fast. Two consecutive seasons of doubled day sale count is the trigger.
How to use the list
These are positions, not purchases. That framing is the whole point. A watch list that does not tell you when you are wrong is a wish list in a trench coat, and the market has enough of those.
- Each name has a single, concrete invalidator. Not a vibe, not a narrative shift, a data point.
- Sizing matters. None of these should be a single-name concentration; think cohort exposure, not lottery tickets.
- Hold period is 24 to 36 months for the compounding names, longer for the blue-chip rerate, which compounds slower but with less tail risk.
What we are not arguing
We are not arguing that any of these names is a guaranteed bid into 2027. We are arguing that each of them has a thesis with a falsifiable stop. That is a materially different claim from the one you will read in most year-end previews, which tend to consist of enthusiasm and a gallery affiliation.
If you cannot state the condition that would make you sell, you do not own a position. You own a hope, which is an expensive thing to store.
The forward view
The most interesting signal to watch across this cohort through 2027 is not price. It is consignment quality. When long-term holders begin to turn fresh-to-market inventory at serious estimates, and those estimates clear, the rerate is real. When the inventory is recycled flips at rising estimates, the rerate is noise. The tape will tell you which one you are in by the second major sale of 2026. Mark the date, check the consignments, and be willing to act on what the tape actually says rather than what the catalogue essay wants it to mean.
Nothing in this article is investment advice. CreativeSlop is an independent publication. Figures rounded for readability. Names of market participants referenced in good faith from on-the-record and on-background conversations.